Cross Country Healthcare Q4 revenue misses estimates

Overview

• Healthcare workforce solutions firm's Q4 revenue fell 24% yr/yr, missing analyst expectations

• Company repurchased over 800,000 shares, or 2.5% of common stock in Q4

Outlook

• Cross Country expects Q1 2026 revenue between $235 mln and $240 mln

• Company anticipates Q1 2026 adjusted EBITDA of $4 mln to $5 mln

• Cross Country projects Q1 2026 adjusted EPS between $(0.06) and $(0.04)

Result Drivers

• GOODWILL IMPAIRMENT - Q4 net loss driven by $77.9 mln goodwill impairment charge following Aya Merger termination

• MARKET CHALLENGES - Revenue decline attributed to challenging market conditions, particularly in travel staffing

Company press release: ID:nBw5MnfjGa

Key Details

Analyst Coverage

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 8 "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the employment services peer group is "buy."

• Wall Street's median 12-month price target for Cross Country Healthcare Inc is $10.50, about 16.9% above its March 3 closing price of $8.98

• The stock recently traded at 94 times the next 12-month earnings vs. a P/E of 102 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.